Screener
Sarepta Therapeutics, Inc. SRPT Noncash Interest Expense
Noncash Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept srpt:NoncashInterestExpense.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
FAQ
- What is Sarepta Therapeutics, Inc.'s noncash interest expense?
- Sarepta Therapeutics, Inc. (SRPT) reported noncash interest expense of $9.39M in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s noncash interest expense changed year-over-year?
- Sarepta Therapeutics, Inc.'s noncash interest expense increased by 596.9% year-over-year, from $1.35M to $9.39M.
- What does noncash interest expense mean?
- Noncash Interest Expense as reported by Sarepta Therapeutics,, Inc. Common Stock.
Ask your AI about Sarepta Therapeutics, Inc.'s noncash interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude